You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.


( se-TUX-i-mab )
New Drug Funding Program
  • Cetuximab and Radiation - Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  • Cetuximab with Irinotecan - Third Line - Metastatic Colorectal Small Bowel or Appendiceal Cancer
Other Name(s): Erbitux®
Appearance: Clear, colorless solution

You might also be interested in